Cas:1158758-77-0 tert-butyl 3-amino-3-methylazetidine-1-carboxylate manufacturer & supplier

Chemical Name:tert-butyl 3-amino-3-methylazetidine-1-carboxylate

CAS.NO:1158758-77-0

Synonyms:1-BOC-3-AMINO-3-METHYL-AZETIDINE;3-Amino-1-Boc-3-methyl-azetidine;TERT-BUTYL 3-AMINO-3-METHYL-AZETIDINE-1-CARBOXYLATE;2-Methyl-2-propanyl 3-amino-3-methyl-1-azetidinecarboxylate;1-Azetidinecarboxylic acid, 3-amino-3-methyl-, 1,1-dimethylethyl ester

Molecular Formula:C₉H₁₈N₂O₂

Molecular Weight:186.251

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:242.5±33.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.487

PSA:55.56000

Exact Mass:186.136826

LogP:0.43

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-BOC-3-AMINO-3-METHYL-AZETIDINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Azetidinecarboxylic acid, 3-amino-3-methyl-, 1,1-dimethylethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,TERT-BUTYL 3-AMINO-3-METHYL-AZETIDINE-1-CARBOXYLATE Use and application,TERT-BUTYL 3-AMINO-3-METHYL-AZETIDINE-1-CARBOXYLATE technical grade,usp/ep/jp grade.

Related News: ��Ultimately, this is a public health decision,�� she said, adding that the restrictions were precautionary measures to keep the country virus-free and contain the worldwide outbreak. tert-butyl 3-amino-3-methylazetidine-1-carboxylate manufacturer As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. tert-butyl 3-amino-3-methylazetidine-1-carboxylate supplier ��Ultimately, this is a public health decision,�� she said, adding that the restrictions were precautionary measures to keep the country virus-free and contain the worldwide outbreak. tert-butyl 3-amino-3-methylazetidine-1-carboxylate vendor Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. tert-butyl 3-amino-3-methylazetidine-1-carboxylate factory ��Ultimately, this is a public health decision,�� she said, adding that the restrictions were precautionary measures to keep the country virus-free and contain the worldwide outbreak.